Pertussis toxin induces angiogenesis in brain microvascular endothelial cells

Journal of Neuroscience Research

Volumn 86, Issue 12, 2008, Pages 2624-2640

  Lu, Changming ^a   Pelech, Steven ^b,c   Zhang, Hong ^b   Bond, Jeffrey ^a   Spach, Karen ^a   Noubade, Rajkumar ^a   Blankenhorn, Elizabeth P ^d   Teuscher, Cory ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b Kinexus Bioinformatics Corporation   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Antibody microarray; Blood brain barrier; Gene microarray; Pertussis toxin; Phosphoproteome; Signal transduction; Transcriptome

Indexed keywords

BETA ARRESTIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; STAT1 PROTEIN; TRANSCRIPTOME;

ALLERGIC ENCEPHALITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION; GENOMICS; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE SCLEROSIS; NEOVASCULARIZATION (PATHOLOGY); NEUROPATHOLOGY; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERTUSSIS TOXIN;

EID: 57049187662     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21716     Document Type: Article

References (110)

1. Albert PR, Robillard L. 2002. G protein specificity: traffic direction required. Cell Signal 14:407-418.
2. Alter A, Duddy M, Hebert S, Biernacki K, Prat A, Antel JP, Yong VW, Nuttall RK, Pennington CJ, Edwards DR, Bar-Or A. 2003. Determinants of human B cell migration across brain endothelial cells. J Immunol 170:4497-4505.
3. Asensio VC, Campbell IL. 1999. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 22:504-512.
4. Bell MD, Taub DD, Perry VH. 1996. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 74:283-292.
5. Ben-Levy R, Leighton IA, Doza YN, Attwood P, Morrice N, Marshall CJ, Cohen P. 1995. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO J 14:5920-5930.
6. Bindewald K, Gunduz D, Hartel F, Peters SC, Rodewald C, Nau S, Schafer M, Neumann J, Piper HM, Noll T. 2004. Opposite effect of cAMP signaling in endothelial barriers of different origin. Am J Physiol Cell Physiol 287:C1246-C1255.
7. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
8. Brabb T, Goldrath AW, von Dassow P, Paez A, Liggitt HD, Goverman J. 1997. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J Immunol 159:497-507.
9. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. Chaudhuri JD. 2000. Blood brain barrier and infection. Med Sci Monit 6:1213-1222.
11. Chng HW, Camplejohn RS, Stone MG, Hart IR, Nicholson LJ. 2006. A new role for the antiapoptotic gene A20 in angiogenesis. Exp Cell Res 312:2897-2907.
12. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. 2000. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279:L429-L438.
13. Deneen B, Welford SM, Ho T, Hernandez F, Kurland I, Denny CT. 2003. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol Cell Biol 23:3897-3908.
14. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG. 2005. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96:881-889.
15. Dormond O, Ruegg C. 2003. Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and protein kinase A. Thromb Haemost 90:577-585.
16. Duran WN, Seyama A, Yoshimura K, Gonzalez DR, Jara PI, Figueroa XF, Boric MP. 2000. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. Microvasc Res 60:104-111.
17. Dzenko KA, Song L, Ge S, Kuziel WA, Pachter JS. 2005. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2. Microvasc Res 70:53-64.
18. Engelhardt B. 2003. Development of the blood-brain barrier. Cell Tissue Res 314:119-129.
19. Engelhardt B, Wolburg H. 2004. Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 34:2955-2963.
20. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L, Boudouresque F. 2004. Effects of adreno-medullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Cancer 108:797-804.
21. Folkman JBH. 1992. Angiogenesis and inflammation. New York: Raven Press. p 821-839.
22. Forget MA, Desrosiers RR, Beliveau R. 1999. Physiological roles matrix metalloproteinases: implications for tumor growth and metastasis. Can J Physiol Pharmacol 77:465-480.
23. Furman B, Sidey FM, Smith M. 1988. Metabolic disturbances produced by pertussis toxin. Chichester, England: John and Wiley and Sons. p 147-172.
24. Gainor JP, Morton CA, Roberts JT, Vincent PA, Minnear FL. 2001. Platelet-conditioned medium increases endothelial electrical resistance independently of cAMP/PKA and cGMP/PKG. Am J Physiol Heart Circ Physiol 281:H1992-H2001.
25. Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki Oberg JO, Osterberg T. 2005. In vitro models for the blood-brain barrier. Toxicol In Vitro 19:299-334.
26. Garcia JG, Davis HW, Patterson CE. 1995. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163:510-522.
27. Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, Varner J. 2005. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 115:1542-1551.
28. Gawlowski DM, Duran WN. 1986. Dose-related effects of adenosine and bradykinin on microvascular permselectivity to macromolecules in the hamster cheek pouch. Circ Res 58:348-355.
29. Gimenez MA, Sim J, Archambault AS, Klein RS, Russell JH. 2006. A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system required for inflammatory infiltration of the spinal cord. Am J Pathol 168:1200-1209.
30. Giovannoni G, Miller DH, Losseff NA, Sailer M, Lewellyn-Smith N, Thompson AJ, Thompson EJ. 2001. Serum inflammatory markers and clinical/ MRI markers of disease progression in multiple sclerosis. J Neurol 248:487-495.
31. Glabinski AR, Tani M, Tuohy VK, Tuthill RJ, Ransohoff RM. 1995. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 9:315-330.
32. Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM. 1997. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150:617-630.
33. Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K. 2001. Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev 36:258-264.
34. Godiska R, Chantry D, Dietsch GN, Gray PW. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J Neuro-immunol 58:167-176.
35. Guo CY, Brautigan DL, Larner JM. 2002. Ionizing radiation activates nuclear protein phosphatase-1 by ATM-dependent dephosphorylation. J Biol Chem 277:41756-41761.
36. Hall H, Djonov V, Ehrbar M, Hoechli M, Hubbell JA. 2004. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis 7:213-223.
37. Hempel A, Noll T, Muhs A, Piper HM. 1996. Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers. Am J Physiol 270:H1264-H1271.
38. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713-726.
39. Huber JD, Egleton RD, Davis TP. 2001. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719-725.
40. Hulkower K, Brosnan CF, Aquino DA, Cammer W, Kulshrestha S, Guida MP, Rapoport DA, Berman JW. 1993. Expression of CSF-1, cfms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol 150:2525-2533.
41. Huxley VH, Williams DA, Meyer DJ Jr, Laughlin MH. 1997. Altered basal and adenosine-mediated protein flux from coronary arterioles isolated from exercise-trained pigs. Acta Physiol Scand 160:315-325.
42. Inoue I, Yanai K, Kitamura D, Taniuchi I, Kobayashi T, Niimura K, Watanabe T, Watanabe T. 1996. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci U S A 93:13316-13320.
43. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15.
44. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. 1995. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155:5003-5010.
45. Kennedy KJ, Strieter RM, Kunkel SL, Lukacs NW, Karpus WJ. 1998. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1. J Neuroimmunol 92:98-108.
46. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, Bonder C, James WG, Robbins SM, Kubes P. 2004. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 173:7070-7077.
47. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. 1995. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517-519.
48. Kohno M, Chatani Y, Tanaka E, Hattori A, Nishizawa N. 1992. Mitogen-induced tyrosine phosphorylation of 41 kDa and 43 kDa proteins. Potential role in integrating multiple mitogenic signalling pathways. Biochem J 287:917-924.
49. Kunz-Schughart LA, Schroeder JA, Wondrak M, van Rey F, Lehle K, Hofstaedter F, Wheatley DN. 2006. Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures from endothelial cells in vitro. Am J Physiol Cell Physiol 290:C1385-C1398.
50. Landry J, Lambert H, Zhou M, Lavoie JN, Hickey E, Weber LA, Anderson CW. 1992. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem 267:794-803.
51. Laschinger M, Engelhardt B. 2000. Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J Neuroimmunol 102:32-43.
52. Li J, Zhao X, Li X, Lerea KM, Olson SC. 2007. Angiotensin II type 2 receptor-dependent increases in nitric oxide synthase expression in the pulmonary endothelium is mediated via a G alpha i3/Ras/Raf/MAPK pathway. Am J Physiol Cell Physiol 292:C2185-C2196.
53. Lin FT, Miller WE, Luttrell LM, Lefkowitz RJ. 1999. Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases. J Biol Chem 274:15971-15974.
54. Lo RK, Wise H, Wong YH. 2006. Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK. Cell Signal 18:307-317.
55. Locht C. 1999. Molecular aspects of Bordetella pertussis pathogenesis. Int Microbiol 2:137-144.
56. Lum H, Malik AB. 1996. Mechanisms of increased endothelial permeability. Can J Physiol Pharmacol 74:787-800.
57. Ma RZ, Gao J, Meeker ND, Fillmore PD, Tung KS, Watanabe T, Zachary JF, Offner H, Blankenhom EP, Teuscher C. 2002. Identification of Bphs, an autoinumme disease locus, as histamine receptor H1. Science 297:620-623.
58. Malergue F, Galland F, Martin F, Mansuelle P, Aurrand-Lions M, Naquet P. 1998. A novel inummoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. Mol Immunol 35:1111-1119.
59. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF. 1998. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 86:20-29.
60. Medhora M, Daniels J, Mundey K, Fisslthaler B, Busse R, Jacobs ER, Harder DR. 2003. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart Circ Physiol 284:H215-H224.
61. Munoz JJ, Bergman R. 1977. Bordetella pertussis, immunological and other biological activities. Rose n, editor. New York: Marcel Dekker. p 186-187.
62. Munoz JJ, Arai H, Bergman RK, Sadowski PL. 1981. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun 33:820-826.
63. 2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. Proc Natld Acad Sci U S A 99:5971-5976.
64. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML. 2001. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 61:6938-6944.
65. Neumann J, Boknik P, Bodor GS, Jones LR, Schmitz W, Scholz H. 1994. Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin. J Pharmacol Exp Ther 269:1310-1318.
66. Noll T, Hempel A, Piper HM. 1996. Neuropeptide Y reduces macro-molecule permeability of coronary endothelial monolayers. Am J Physiol 271:H1878-H1883.
67. Olofsson PS, Jatta K, Wagsater D, Gredmark S, Hedin U, Paulsson-Berne G, Soderberg-Naucler C, Hansson GK, Sirsjo A. 2005. The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol 25:e113-e116.
68. Osinde M, Mullershausen F, Dev KK. 2007. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 52:1210-1218.
69. Patterson CE, Stasek JE, Schaphorst KL, Davis HW, Garcia JG. 1995. Mechanisms of perrussis toxin-induced barrier dysfunction in bovine pulmonary artery endothelial cell monolayers. Am J Physiol 268:L926-L934.
70. Patterson CE, Lum H, Schaphorst KL, Verin AD, Garcia JG. 2000. Regulation of endothelial barrier function by the cAMP-dependent protein kinase. Endothelium. 7:287-308.
71. Pelech S, Zhang H. 2003. Cancer cell signalling Kinetworks protein kinase multiblot analysis. Terrian D, editor: Totowa, NJ: Humana Press. p 99-111.
72. Pepper, MS, Montesano R, Mandriota SJ, Orci L, Vassalli JD. 1996. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49:138-162.
73. Phillips K, Kedersha N, Shen L, Blackshear PJ, Anderson P. 2004. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci U S A 101:2011-2016.
74. Polverini PJ. 1995. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 6:230-247.
75. Post GR, Brown JH. 1996. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 10:741-749.
76. Prat A, Biernacki K, Lavoie JF, Poirier J, Duquette P, Antel JP. 2002. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch Neurol 59:391-397.
77. Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ. 2002. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 61:914-925.
78. Qureshi ST, Uriviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189:615-625.
79. Racke MK, Hu W, Lovett-Racke AE. 2005. PTX cruiser: driving auto-immunity via TLR4. Trends Immunol 26:289-291.
80. Ranieri G, Ria R, Roccaro AM, Vacca A, Ribatti D. 2005. Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases. Curr Drug Targets Inflamm Allergy 4:13-22.
81. RansohofF RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Trohy VK. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7:592-600.
82. Raught B, Gingras AC, Gygi SP, Imataka H, Morino S, Gradi A, Aebersold R, Sonenberg N. 2000. Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J 19:434-444.
83. Sarma V, Wolf FW, Marks RM, Shows TB, Dixit VM. 1992. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J Inummol 148:3302-3312.
84. Sollevi A, Fredholm BB. 1981. Role of adenosine in adipose tissue circulation. Acta Physiol Scand 112:293-298.
85. Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV. 2003. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via a. Rho and Rho kinase. J Cell Sci 116(Pt 22):4615-4628.
86. Stelzner TJ, Weil JV, O'Brien RF. 1989. Role of cyclic adenosine monophosphate in the induction of endothehal barrier properties. J Cell Physiol 139:157-166.
87. Stasek JE Jr, Patterson CE, Garcia JG. 1992. Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary, artery endothelial cell monolayers. J Cell Physiol 153:62-75.
88. Strnad CF, Carchman RA. 1987. Human T lymphocyte mitogenesis in response to the B oligomer of pertussis toxin is associated with an early elevation in cytosolic calcium concentrations. FEBS Lett 225:16-20.
89. Su JY, Vo AC. 2007. 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling. Eur J Pharmacol 559:189-195.
90. Susa M, Standke GJ, Jeschke M, Rohner D. 1997. Fluoroaluminate induces pertussis toxin-sensitive protein phosphorylation: differences in MC3T3-E1 osteoblastic and NIH3T3 fibroblastic cells. Biochem Biophys Res Commun 235:680-684.
91. Takahashi Y, Li L, Kamiryo M, Asteriou T, Moustakas A, Yamashita H, Heldin P. 2005. Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J Biol Chem 280:24195-24204.
92. Tamura M, Nogimori K, Murai S, Yajima M, Ito K, Katada T, Ui M, Ishii S. 1982. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 21:5516-5522.
93. Tani M, Fuentes ME, Peterson JW, Trapp BD, Durham SK, Loy JK, Bravo R, Ransohoff RM, Lira SA. 1996. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/ KC in oligodendrocytes. J Clin Invest 98:529-539.
94. Teuscher C, Bunn JY, Filtmore PD, Butterfield RJ, Zachary JF, Blankenhorn EP. 2004. Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am J Pathol 165:1593-1602.
95. Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS, Perantoni AO. 2006. Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 25:7555-7564.
96. Tsuji T, Karasek MA. 1985. A new method for obtaining scanning electron microscopic images of the reorganization process of human dermal microvascular endothelium in vitro. J Microsc 137:75-83.
97. Uthaiah RC, Praefcke GJ, Howard JC, Herrmann C. 2003. IIGP1, an interferon-gamma-inducible 47-kDa GTPase of the mouse, showing cooperative enzymatic activity and GTP-dependent multimerization. J Biol Chem 278:29336-29343.
98. Vailhe B, Vittet D, Feige J-J. 2001 In vitro models of vasculogenesis and angiogenesis. Lab Invest 81:439-452.
99. spontaneous angiogenesis in vitro": planar cultures as models of vascular development. In Vitro Cell Dev Biol Anim 31:120-131.
100. Wardlaw AC, Parton R. 1982. Bordetella pertussis toxins. Pharmacol Ther 19:1-53.
101. Watanabe H, Kuhne W, Schwartz P, Piper HM. 1992. A2-adenosine receptor stimulation increases macromolecule permeability of coronary endothelial cells. Am J Physiol 262:H1174-H1181.
102. Watts VJ. 2002. Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther 302:1-7.
103. Wilson CL, Miller CJ. 2005. Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 21:3683-3685.
104. Wolburg H, Lippoldt A. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc Pharmacol 38:323-337.
105. Zeng H, Zhao D, Mukhopadhyay D. 2002. Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. J Biol Chem 277:4003-4009.
106. Zeng H, Zhao D, Yang S, Datta K, Mukhopadhyay D. 2003. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling. J Biol Chem 278:20738-20745.
107. Zharikov SI, Krotova KY, Belayev L, Block ER. 2004. Pertussis toxin activates L-arginine uptake in pulmonary endothelial cells through downregulation of PKC-alpha activity. Am J Physiol Lung Cell Mol Physiol 286:L974-L983.
108. Zheng CF, Guari KL. 1994. Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. ENOO J 13:1123-1131.
109. Ziche M, Morbidelli L. 2000. Nitric oxide and angiogenesis. J Neurooncol 50:139-148.
110. Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero, S. 2004. Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103:4536-4544.